Aspergillus and Mucorales species cause severe infections in patients with leukemia and those who have undergone allogeneic hematopoietic stem cell transplantation (HSCT) [1, 2] .
Antifungal prophylaxis or treatment in high-risk patients with prolonged neutropenia, T-cell suppression, or graft-versus-host disease (GVHD) is often ineffective owing to impaired host immunity and may result in the emergence of uncommon or resistant molds. Treatments are furthermore associated with drug interactions, toxicity, and high costs [2] . Hence, treatment approaches that restore or boost fungus-specific immunity would be desirable.
Adoptive T-cell therapy using T-cell clones generated by stimulation with Aspergillus fumigatus conidia in patients with invasive aspergillosis after haploidentical HSCT was promising [3] . However, reproducibility is difficult because of the variation of stimuli and the elaborate production required for compliance with good manufacturing practices.
Therefore, it is crucial to identify immunogenic proteins and peptides in healthy individuals and patients with invasive aspergillosis. This is challenging, however, because the A. fumigatus genome encodes for approximately 10 000 genes [4] . Until now, several immunogenic proteins and T-cell epitopes have been characterized in healthy individuals and mice, such as extracellular cell wall glucanases Crf1, Crf2, Scw4 [5] [6] [7] [8] [9] , 1,3-β-glucanosyl-transferase Gel1 [6, 8, 9] , GPI-anchored protein PST1 [9] , mycelial catalase 1 [6, 7, 9] , serine hydroxylmethyltransferase 2 [9] , aspartic protease Pep1 [6, 8] , enolase Aspf22 [9, 10] , manganese superoxide dismutase Sod2 [9, 10] , and cytosolic peroxisomal peroxiredoxin Pmp20 (Asp f3) [9] [10] [11] . Only recently, T-cell responses to some of these proteins have been shown to correlate with a beneficial outcome in patients with invasive aspergillosis [8, 12] . Furthermore, it would be desirable that these antigen-specific T cells recognize additional clinically relevant molds.
To facilitate adoptive therapy for invasive aspergillosis, the generation of T-cell products needs to be rapid, to be specific, and to comply with GMP. The CliniMACS IFN-γ Cytokine Capture System that has so far been successfully applied for the generation of virus-specific T cells [13] [14] [15] shows limited sensitivity for antigens with low T-cell precursor frequencies [16] . Therefore, other T-cell activation markers that enable selection of antigen-specific T cells with higher sensitivity and irrespective of cytokine production may be more suitable. Selection methods based on activation-dependent expression of CD154 or CD137 have recently been shown to be promising candidates [9, 17, 18] . Moreover, the Clini-MACS CD137 isolation reagents were deemed in 2013 to comply with GMP, but their clinical use has not yet been demonstrated.
Here, we characterized the T-cell repertoire specific to different Aspergillus-derived peptide pools and epitopes in healthy individuals and patients after HSCT and compared the CD154-and CD137-based isolation methods for specificity and cross-reactive potential.
MATERIALS AND METHODS

Fungal Antigens
Aspergillus fumigatus lysate and Crf1, Gel1, and Pmp20 peptide pools (Miltenyi Biotec) and custom-made peptide libraries of Gel1 and Pmp20 (Proimmune) consisting of 111 and 40 15-mer peptides overlapped by 4 amino acids with a purity of >70% and the Crf1/p41 FHTYTIDWTKDAVTW (JPT Peptide Technologies) were reconstituted at 5 µg/µL in dimethyl sulfoxide (Sigma-Aldrich).
Generation of Heat-Inactivated Fungi
Aspergillus fumigatus strain D141 and clinical fungal isolates were provided by Prof Dr Sven Krappmann (Medical Immunology Campus Erlangen, Germany) and Dr Reno Frei (University Hospital Basel, Switzerland), respectively, and were cultured and heat inactivated as described elsewhere [5] .
In Vitro Stimulation, Epitope Mapping, and CD137 + and CD154
+ Selection
Blood specimens were obtained from healthy donors and patients after receipt of informed consent and in accordance with a protocol approved by the Ethics Commission of Northwest and Central Switzerland. Isolation of peripheral blood mononuclear cells (PBMCs) and generation of dendritic cells (DCs) and macrophages were performed as published previously [5] .
To generate antigen-specific T-cell lines, PBMCs were stimulated for 7 days with A. fumigatus lysate (50 µg/mL), Crf1, Pmp20, or Gel1 peptide pools (1 µg/peptide/mL) with 5 U/mL interleukin 2 (Proleukin, Chiron [16] . The cell lines were expanded as described elsewhere [19] .
Functionality Assays and Flow Cytometry
Interferon γ (IFN-γ), interleukin 17 (IL-17), interleukin 10 (IL-10), and interleukin 4 (IL-4) enzyme-linked immunosorbent spot (ELISPOT) analyses were performed according to the manufacturers' instructions, as published previously [16] . The number of spot-forming cells was counted by an ELISPOT reader (Cellular Technologies). For proliferation, PBMCs were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE; Invitrogen) according to the manufacturer's instructions and were stimulated with antigens for 8 or 10 days. Intracellular cytokine (ICC) staining was performed as described elsewhere [16] . Cells were stained with Zombie-Aqua-Fixable-Viability Kit, anti-CD4-PacificBlue, anti-CD8-allophycocyanin, anti-CD3-peridinin chlorophyll protein antibodies (all Biolegend), and, for ICC, anti-IFN-γ-phycoerythrin (PE) antibody (Miltenyi Biotech) and acquired on a BD LSRFortessa system (BD Biosciences). Data were analyzed with FlowJo software vX.0.7.
The A. fumigatus Crf1/p41-specific major histocompatibility complex class II tetramer DRB1*0401 FHTYTIDWTKDAVTW, labeled with PE (Beckman Coulter), was used according to the manufacturers' instructions.
Granulocyte macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor α (TNF-α), IL-10, and transforming growth factor β (TGF-β) levels were determined in culture supernatant after 48 hours stimulation ( [16] . The counts per minute were determined using a liquid scintillation counter.
Statistical Analysis
Data were analyzed by GraphPad Prism 6.0 (GraphPad Software). The statistical tests used for statistical analyses are indicated in the figure legends. P values of < .05 were considered statistically significant.
RESULTS
A. fumigatus Lysate and Peptide Pools of Crf1, Gel1, and Pmp20 Induce Similar and Predominant T h 1 Responses
To identify immunogenic A. fumigatus antigens, we compared A. fumigatus lysate, which complies with GMP, to commercially available Crf1, Gel1, and Pmp20 peptide pools in healthy donors (n ≥ 8). Most of the donors showed IFN-γ production to at least 2 of 3 tested peptide pools after 7 days of in vitro stimulation, indicating that T cells specific for these antigens are present in the healthy population. The response to peptide pools was comparable to stimulation with A. fumigatus lysate, except for Gel1, which had a lower stimulatory capacity. There was only low IL-17, IL-4, and IL-10 production detected, except for A. fumigatus lysate, which induced a higher IL-10 response ( Figure 1A ). Since recent publications indicated that, in addition to CD4 + T h 1 cells, CD8 + T cells induce protective antifungal immune responses [20, 21] , we next determined the cellular source of IFN-γ. As for Crf1 [5] , most individuals showed a dominant CD4 + T-cell response. Only Pmp20 induced, in 2 of 6 donors, a CD8 + T-cell response comparable to or even higher than the CD4 + Tcell response ( Figure 1B ). To verify these data, we determined T-cell proliferation by CFSE staining, which confirmed the predominance of CD4 + T-cell expansion toward all antigens ( Figure 1C ).
In conclusion, in most healthy donors, the peptide pools Crf1, Gel1, and Pmp20 induced a T h 1 response that was comparable in magnitude and cytokine profile to stimulation with A. fumigatus lysate.
Patients With Active Invasive Aspergillosis Respond to
A. fumigatus Antigens Irrespective of Absolute CD4 + T-Cell
Count and Show Expansion Over Time
To clarify whether T cells specific for A. fumigatus Crf1, Gel1, and Pmp20 play a role during invasive aspergillosis, we analyzed the IFN-γ response to these antigens in 5 patients with active invasive aspergillosis currently under control by antifungal therapy and in 8 patients without any fungal infection or antimold treatment before or after HSCT (Supplementary Table 1 ). Samples were obtained from patients 5-19 months after HSCT. Importantly, patients with active invasive aspergillosis showed high IFN-γ responses to all antigens, regardless of absolute CD4 + T-cell counts and GVHD (Figure 2A ), while patients without fungal infection showed comparable immune responses only with higher CD4 + T-cell counts ( Figure 2B ). IL-17
and IL-4 production was low in both groups (data not shown). Furthermore, using the previously described HLA-DRB1*04 tetramer, 1 patient with well-controlled invasive aspergillosis experienced expansion of Crf1/p41 tetramer-specific cells from an undetectable level to 1.35% of CD4 + T cells over 10 weeks, which corresponded to an improvement of the pulmonary lesion detected by computed tomography ( Figure 2C ). In patients without invasive aspergillosis, as well as in a patient with invasive aspergillosis with poor outcome, Crf1/p41-specific cells were not detectable (data not shown). Taken together, T cells specific for Crf1, Gel1, and Pmp20 were detectable in peripheral blood specimens from patients with well-controlled invasive aspergillosis, irrespective of CD4 + T cell recovery and GVHD, and Crf1/p41-specific cells expanded over time, concomitantly improving the fungal lesions, suggesting that these cells may contribute to the control of invasive aspergillosis.
Identification of Immunodominant Epitopes of Gel1 and Pmp20
Because of the promising results, we aimed to identify immunodominant peptide epitopes of these proteins. As peptide epitopes for Crf1 have been previously characterized [5, 7, 12] , we focused on Gel1 and Pmp20. The mapping procedure is shown in Supplementary Figure 1 . Only 5 of 19 and 6 of 17 healthy donors recognized the most common epitopes for Gel1 and Pmp20, respectively, and the overall responses were lower than responses to the complete peptide pools (Table 1) . We therefore decided to use the complete peptide pools instead of single epitopes for further experiments.
A. fumigatus-Specific T Cells Can Be Isolated on the Basis of Activation-Dependent Surface Expression of CD137 and CD154
To generate pathogen-specific T cells for adoptive transfer, rapid isolation methods for direct infusion are needed. We compared the previously described CD154-based selection method to the CD137 selection method, recently judged to be in compliance with GMP. We performed the selections 14 hours after antigenic stimulation, because surface expression of CD137 and CD154 was highest after 14-24 hours, with decreased viability after 24 hours (data not shown).
T cells specific for A. fumigatus lysate, the peptide pools Crf1, Gel1, and Pmp20 or the combination of all 3 peptide pools (C -+ G + P) were enriched from PBMCs of 4 healthy donors. A median of 1.6 × 10 5 cells for CD137 and 1.8 × 10 5 cells for CD154 selection were isolated from 7 × 10 7 PBMCs, respectively (Supplementary Figure 2A) . The viability of the selected cells was higher than 95% and similar for both selection methods. There were no differences between A. fumigatus lysate and the different peptide pools. The percentage of cells expressing the activation marker after isolation was significantly higher for CD137, compared with CD154 selection (median, 48.8% and 2.9%, respectively; P ≤ .01 for all lines; Figure 3A and 3B). However, part of the CD137 population had probably been enriched unspecifically, because CD137 expression was detected in unstimulated controls on up to 2.5% of lymphocytes (data not shown). As expected, CD154-based selection favored CD4 + T cells (median, 79.8%), whereas after CD137 selection only a median of Figure 3C and data not shown).
In conclusion, CD137-and CD154-based isolation allowed selection of A. fumigatus lysate and peptide-specific T cells with similar cell numbers and viability. The percentage of cells expressing CD137 was significantly higher than of CD154, probably because of unspecific enrichment.
Aspergillus-Specific T-Cell Lines Show a Predominant T h 1 Cytokine Profile
The cell populations isolated by CD137 and CD154 expression could be expanded by a median of 22-fold and 27-fold, respectively (Supplementary Figure 2B) , and the percentage of the different subpopulations remained unchanged for CD154-selected lines but showed an increase of CD4 + T cells after CD137 selection ( Figures 3C and 4A) . The expanded T-cell lines of all donors showed similar specificity, as evaluated by IFN-γ ICC staining, independent of antigen and selection method, despite the higher purity after CD137 selection confirming unspecific expression ( Figure 4B) . In all lines, the response was predominately mediated by CD4 + T cells, except in 2 donors, who showed high CD8 + T-cell responses in CD137-selected Pmp20 and Crf1 + Gel1 + Pmp20-specific lines.
To further characterize the cytokine profile we analyzed IL-17, IL-4, GM-CSF, TNF-α, IL-10, and TGF-β secretion. The cytokine responses were similar for all CD137-and CD154-selected lines, and in addition to IFN-γ, all antigens induced high production of IL-17 and GM-CSF and low production of TNF-α, IL-10, and TGF-β ( Figure 4C and 4D and data not shown). The only difference was the higher IL-4 response in the lines specific for A. fumigatus lysate, compared with the other cell lines.
T-Cell Lines Generated With Crf1 + Gel1 + Pmp20 Remain Multispecific
As the combination of all 3 peptide pools could potentially cover a broader repertoire of Aspergillus-specific T cells than the single pools, we investigated whether T-cell lines generated with Crf1, Gel1, and Pmp20 were specific to all antigens. Indeed, all multispecific T-cell lines showed specificity for all 3 peptide pools ( Figure 4E ), indicating limited antigenic competition and the feasibility of this combinatory approach.
Generated T-Cell Lines Respond to Naturally Processed Fungi and Cross-react to Aspergillus and Mucorales Species and Candida albicans
We further investigated the ability of the T-cell lines to respond to naturally processed A. fumigatus. Overall, multispecific lines showed higher IFN-γ and IL-17 responses to A. fumigatus hyphae than single-specific lines, and the CD154-selected lines responded better than the CD137 lines ( Figure 5A and 5C).
As HSCT recipients are highly susceptible to other mold and yeast infections, we challenged the expanded cell lines with clinical isolates of different Aspergillus species (A. flavus, A. terreus, and A. niger), Scedosporium apiospermum, Scedosporium prolificans, Fusarium solani, Rhizopus microsporus, Lichtheimia corymbifera, and Candida albicans. As shown in Figure 5A and 5C, the CD154-generated multispecific lines showed high IFN-γ and IL-17 responses to all Aspergillus species, Mucorales species, and C. albicans, but responses to Fusarium and Scedosporium species were not as strong. The CD137-selected cells showed overall lower responses to A. fumigatus and other molds. By contrast, all cell lines generated with lysate cross-reacted to all fungi ( Figure 5B and 5D) .
In summary, multispecific T-cell lines, particularly those selected by CD154, respond to naturally processed Aspergillus species, Mucorales species, and C. albicans rendering them highly applicable for clinical use.
Alloreactivity of Ex Vivo-Generated T-Cell Lines to Third-Party DCs Is Significantly Reduced
Because adoptive transfer of donor-derived T cells into HSCT recipients may induce GVHD, we assessed their alloreactivity. All lines, regardless of antigen or isolation method, showed significantly reduced alloreactivity to γ-irradiated, partially mismatched third-party DCs, compared with autologous PBMCs (Figure 6 ). 
DISCUSSION
In this study we show that A. fumigatus proteins Crf1, Gel1, and Pmp20 are immunogenic and likely protective by inducing T h 1-cell responses in healthy individuals and patients with active invasive aspergillosis after HSCT. Based on activation-dependent expression of CD137 or CD154, these cells can be selected and show similar specificity. Moreover, the multispecific CD154-selected lines cross-react to the most relevant human-pathogenic molds. Therefore, our results greatly foster adoptive T-cell transfer for these problematic infections. Clinical application of adoptive T-cell transfer strongly relies on identification of potent and safe fungal antigens. This is challenging, however, owing to the high number of fungal proteins. We focused on Crf1, Gel1, and Pmp20 because previous studies indicated high immunogenicity in healthy individuals or mice [5, 6, 10, 12, 22, 23] , commercial availability, and potential cross-reactivity to other human-pathogenic fungi [5, 6] . We detected IFN-γ responses primarily mediated by CD4 + T h 1 cells to at least 2 of 3 peptide pools in all healthy donors. A recent study reported lower responses to Gel1 and Pmp20, compared with Crf1, which may be due to the different experimental setups. But these findings also support interindividual variability of the immune responses [9] . Nevertheless, patients with active invasive aspergillosis responded similarly to these antigens, regardless of CD4 + T-cell Figure 3 . Aspergillus fumigatus-specific T cells can be isolated on the basis of activation-dependent expression of CD137 and CD154. A, Peripheral blood mononuclear cells (PBMCs) from healthy donors were stimulated for 14 hours with different A. fumigatus antigens, and specific cells were isolated by CD137 or CD154 positive selection. Shown are the positive fractions gated on lymphocytes from 1 representative donor (n = 4). B, The purity of CD137 and CD154-positive fractions of 5 different antigens (n = 4). The purity of CD137-selected lines is significantly higher than that of CD154-selected lines for all antigens (P ≤ .01, by 2-way analysis of variance with the Bonferroni multiple comparisons test). C, Phenotypic characterization of the isolated CD137 + and CD154 + cells in the positive fractions. The abbreviation "C + G + P" indicates that all 3 antigens-Crf1, Gel1, and Pmp20-were used for stimulation.
counts and GVHD, and the recovery of Crf1/p41-specific T cells could be longitudinally monitored in a patient with improving fungal lesions. These data are in line with 2 recent publications showing the induction of IFN-γ responses to A. fumigatus Crf1 and Gel1 [8, 12] and additionally reveal that Pmp20-specific T cells are also expanding in patients with invasive aspergillosis with a beneficial outcome, suggesting that these peptide-specific T cells help to control the infection. These findings strengthen the use of these candidate antigens for T-cell immunotherapy. We further saw that Pmp20 induced high responses in CD8 + T cells in some donors, which could be particularly relevant for HSCT recipients early during immune recovery, when CD4 + T-cell reconstitution is frequently delayed [24] . To date, there is scarce knowledge about the required T-cell epitopes and their HLA coverage that induce high numbers of polyclonal CD4 + and CD8 + cells effective against mold infections. Similar to the approach used in the development of Epstein-Barr virus-specific T cells [14] , we intended to generate a mixed peptide pool containing the most immunogenic epitopes from different A. fumigatus proteins. However, as compared to the previously identified Crf1 epitopes in humans [5, 7, 25] , we did not find any highly immunogenic T-cell epitopes for Pmp20 and Gel1. The generation of a T-cell product for adoptive transfer should be fast and simple, to be administered in a timely manner to patients in need. To avoid ex vivo expansion, we compared the CD154 method to the CD137 selection method, which was recently found to comply with GMP but has not yet been used in a clinical setting. The isolated cell number, viability, expansion potential, cytokine profile, and alloreactivity were comparable between all cell lines and independent of the selection method or the antigen. Importantly, our T-cell lines stimulated with all 3 peptide pools remained multispecific. This is in line with our previous findings, in which activationdependent expression of CD154 allowed selection of T cells specific for 3 viral and 2 fungal pathogens [16] . We isolated a median of 0.25% of the starting cell fraction. A clinical scale stimulation starting with 1 × 10 9 PBMCs would therefore yield The abbreviation "C + G + P" indicates that all 3 antigens-Crf1, Gel1, and Pmp20-were used for stimulation.
around 2× 10 6 -3 × 10 6 cells, which is comparable to the numbers used for antiviral T-cell transfer [13, 26, 27] , suggesting that the number of isolated CD137 + or CD154 + T cells could be enough for the reconstitution of fungus-specific immunity without the need of ex vivo expansion. These cells could be particularly suitable for lymphopenic patients after neutrophil engraftment, to support the effector functions of the neutrophils and macrophages to prevent or treat invasive aspergillosis [28] .
In line with the protective immunity of T h 1 cells, the cytokine profile of CD137 and CD154-selected cell lines was dominated by the T h 1 cytokines IFN-γ and GM-CSF. The cell lines additionally produced IL-17, which is in general regarded as an important cytokine in antifungal immunity [28] . In vitrostimulated PBMCs showed very low IL-17 production, indicating that the culture conditions during expansion probably favored proliferation of the T h 17 subset. Direct infusion of the isolated cells should circumvent this imbalance. We furthermore excluded the presence of regulatory T cells, as previous results have postulated their enrichment after CD137 selection [29, 30] , and of T h 2 cells, which are associated with antiinflammatory responses [23, 28] .
The percentage of cells expressing the activation marker was significantly higher for CD137 selection than for CD154 selection, with median values of 48.8% and 2.9%, respectively. This is probably due to low expression and fast downregulation of CD154 leading to an underestimation of positive cells [16] and to unspecific expression of CD137 causing overestimation, indicating that activation marker expression cannot be equated with antigen specificity. Compared with CD154 selection, which strongly favors enrichment of CD4 + T cells [17] , CD137-selected cells were more diverse and additionally included high numbers of natural killer cells and γδ T cells. These cells are increasingly recognized to contribute to antifungal immunity [31] [32] [33] [34] [35] [36] , and recent studies in patients with solid tumors or hematological malignancies demonstrated their safety [37] . In the last decade, infections with other Aspergillus and Mucorales species have increasingly been reported [38] [39] [40] . We have previously shown that CD4 + T cells specific for the A. fumigatus Crf1/p41 epitope confer cross-reactivity to C. albicans [5] , and a potential cross-reactivity of Gel1 was suggested in a mouse model [6] . In particular, T-cell lines specific for all 3 antigens and selected by CD154 expression not only efficiently recognized naturally processed A. fumigatus, but also cross-reacted to different clinically relevant Aspergillus species and the Mucorales species, Rhizopus microsporus, and Lichtheimia corymbifera, suggesting that adoptively transferred T cells could very likely protect the recipients against a variety of fungal infections. It remains unclear, however, which epitopes confer cross-reactivity, as BLAST analysis indicated only limited genetic similarity between these fungi. Compared with the peptide pools, A. fumigatus lysate-specific lines cross-reacted to all tested molds and yeast. This may be explained by the fact that lysate contains various cell wall components that are less diverse between different fungal species, compared with protein antigens [41] . On the other hand, some cell wall components, such as galactosaminogalactan, are able to actively inhibit the induction of protective responses [42] . This might also explain the high level of IL-10 secretion in PBMCs stimulated with fungal lysate, which could be mediated by T cells as well as monocytes, and the higher IL-4 response in lysate-specific as compared to peptide-specific lines. The immune response induced by lysate is therefore less predictable and could potentially reduce the efficacy of a T-cell product. By contrast, the combination of all 3 peptide pools is highly suitable for the generation of mold-specific T cells, because it probably covers a wider range of HLA types, induces higher numbers of polyclonal CD4 + and CD8 + T cells, confers crossreactivity to different fungi, and appears to be safe.
In conclusion, T cells specific for A. fumigatus Crf1, Gel1, and Pmp20 selected by activation-dependent CD137 or CD154 expression may form the basis for adoptive T-cell transfer for prophylaxis in high-risk patients or for treatment in patients with refractory mold infections.
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